Yuhuan Zheng

Department of Hematology/Institute of Hematology, Sichuan University

Research Area

Biography

Yuhuan Zheng has not added Biography.
If you are Yuhuan Zheng and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title	2025

Other Publications

Article	Year
Discrepancies between clinical staging and pathological findings of operable cervical carcinoma with stage IB-IIB: a retrospective analysis of 818 patients. The Australian & New Zealand journal of obstetrics & gynaecology\| PubMed ID: 19780741	2009
Chemokines CCL2, 3, 14 stimulate macrophage bone marrow homing, proliferation, and polarization in multiple myeloma. Oncotarget\| PubMed ID: 26155942	2015
PIG7 promotes leukemia cell chemosensitivity via lysosomal membrane permeabilization. Oncotarget\| PubMed ID: 26716897	2016
Role of Myeloma-Derived MIF in Myeloma Cell Adhesion to Bone Marrow and Chemotherapy Response. Journal of the National Cancer Institute\| PubMed ID: 27381622	2016
Microarray-based analysis and clinical validation identify ubiquitin-conjugating enzyme E2E1 (UBE2E1) as a prognostic factor in acute myeloid leukemia. Journal of hematology & oncology\| PubMed ID: 27855695	2016
High-expressing cystic fibrosis transmembrane conductance regulator interacts with histone deacetylase 2 to promote the development of Ph+ leukemia through the HDAC2-mediated PTEN pathway. Leukemia research\| PubMed ID: 28235656	2017
High CFTR expression in Philadelphia chromosome-positive acute leukemia protects and maintains continuous activation of BCR-ABL and related signaling pathways in combination with PP2A. Oncotarget\| PubMed ID: 28445932	2017
Therapeutic effects of CSF1R-blocking antibodies in multiple myeloma. Leukemia\| PubMed ID: 28626216	2018
Chidamide and decitabine can synergistically induce apoptosis of Hodgkin lymphoma cells by up-regulating the expression of PU.1 and KLF4. Oncotarget\| PubMed ID: 29100410	2017
Combination of IKZF1 deletion and early molecular response show significant roles on prognostic stratification in Philadelphia chromosome-positive acute lymphoblastic leukemia patients. Leukemia & lymphoma\| PubMed ID: 29214878	2018
Prognostic value of diametrically polarized tumor-associated macrophages in multiple myeloma. Oncotarget\| PubMed ID: 29348856	2017
Young female patients with multiple myeloma have low occurrence of osteolytic lesion. Bone\| PubMed ID: 29414597	2018
Correction: Chidamide and decitabine can synergistically induce apoptosis of Hodgkin lymphoma cells by up-regulating the expression of PU.1 and KLF4. Oncotarget\| PubMed ID: 29766990	2018
Hypoxia with Wharton's jelly mesenchymal stem cell coculture maintains stemness of umbilical cord blood-derived CD34 cells. Stem cell research & therapy\| PubMed ID: 29895317	2018
SLC2A5 overexpression in childhood philadelphia chromosome-positive acute lymphoblastic leukaemia. British journal of haematology\| PubMed ID: 30272826	2018
The Correlation of Symptom Clusters and Functional Performance in Adult Acute Leukemia Patients Under Chemotherapy. Cancer nursing\| PubMed ID: 32404584	2021
PIM3 Promotes the Proliferation and Migration of Acute Myeloid Leukemia Cells. OncoTargets and therapy\| PubMed ID: 32764981	2020
Low-dose ruxolitinib shows effective in treating myelofibrosis. Annals of hematology\| PubMed ID: 33083863	2021
Homoharringtonine synergizes with quizartinib in FLT3-ITD acute myeloid leukemia by targeting FLT3-AKT-c-Myc pathway. Biochemical pharmacology\| PubMed ID: 33831397	2021
BMI1 regulates multiple myeloma-associated macrophage's pro-myeloma functions. Cell death & disease\| PubMed ID: 33993198	2021
The Feasibility and Efficacy of Self-help Relaxation Exercise in Symptom Distress in Patients With Adult Acute Leukemia: A Pilot Randomized Controlled Trial. Pain management nursing : official journal of the American Society of Pain Management Nurses\| PubMed ID: 34052118	2021
Prognostic significance of p53, Sox11, and Pax5 co-expression in mantle cell lymphoma. Scientific reports\| PubMed ID: 34099776	2021
Intratumor Heterogeneity of MIF Expression Correlates With Extramedullary Involvement of Multiple Myeloma. Frontiers in oncology\| PubMed ID: 34268123	2021
ALCAM-EGFR interaction regulates myelomagenesis. Blood advances\| PubMed ID: 34592762	2021
Minimal residual disease in multiple myeloma: current status. Biomarker research\| PubMed ID: 34649622	2021
Differential mA RNA landscapes across hematopoiesis reveal a role for IGF2BP2 in preserving hematopoietic stem cell function. Cell stem cell\| PubMed ID: 34678169	2022
Circulating exosomal microRNAs as diagnostic and prognostic biomarkers in patients with diffuse large B-cell lymphoma. Hematological oncology\| PubMed ID: 34874565	2022
Cancer-Cell-Biomimetic Nanoparticles for Targeted Therapy of Multiple Myeloma Based on Bone Marrow Homing. Advanced materials (Deerfield Beach, Fla.)\| PubMed ID: 34877715	2022
The expression and clinical significance of programmed cell death receptor 1 and its ligand in tumor tissues of patients with extranodal nasal NK/T cell lymphoma. Scientific reports\| PubMed ID: 34996890	2022
Estrogen-Responsive Gene MAST4 Regulates Myeloma Bone Disease. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research\| PubMed ID: 35064934	2022
ALCAM regulates multiple myeloma chemoresistant side population. Cell death & disease\| PubMed ID: 35145058	2022
Symptom clusters and quality of life in ambulatory patients with multiple myeloma. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer\| PubMed ID: 35182229	2022
Compassion satisfaction and compassion fatigue in haematology cancer nurses: A cross-sectional survey. Nursing open\| PubMed ID: 35527343	2022
Pathogenesis and treatment of multiple myeloma. MedComm\| PubMed ID: 35665368	2022
Dasatinib and interferon alpha synergistically induce pyroptosis-like cell death in philadelphia chromosome positive acute lymphoblastic leukemia. American journal of cancer research\| PubMed ID: 35812060	2022
ISG20L2 suppresses bortezomib antimyeloma activity by attenuating bortezomib binding to PSMB5. JCI insight\| PubMed ID: 36040812	2022
A novel immune prognostic model of non-M3 acute myeloid leukemia. American journal of translational research\| PubMed ID: 36105048	2022
A stratified therapeutic model incorporated with studies on regulatory B cells for elderly patients with newly diagnosed multiple myeloma. Cancer medicine\| PubMed ID: 36127626	2023
Liposome-Encapsulated Melphalan Exhibits Potent Antimyeloma Activity and Reduced Toxicity. ACS omega\| PubMed ID: 36643473	2023
A systematic review on performance analysis of critical time points in multiple myeloma treated by CAR-T cell immunotherapy. International immunopharmacology\| PubMed ID: 36700772	2023
Treatment attrition rates and relevant risk factors in multiple myeloma: A real-world study in China. Frontiers in pharmacology\| PubMed ID: 36713847	2023
Optimal timing and drug combination of selinexor in multiple myeloma: a systematic review and meta-analysis. Hematology (Amsterdam, Netherlands)\| PubMed ID: 36920065	2023
Combinations of ivermectin with proteasome inhibitors induce synergistic lethality in multiple myeloma. Cancer letters\| PubMed ID: 37149018	2023
[Progress in Chimeric Antigen Receptor-Modified Natural Killer Cells for Multiple Myeloma]. Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae\| PubMed ID: 37157078	2023
Efficacy and safety of histone deacetylase inhibitors in peripheral T-cell lymphoma: a systematic review and meta-analysis on prospective clinical trials. Frontiers in oncology\| PubMed ID: 37384289	2023
[Advances in Modeling of Multiple Myeloma in Mice]. Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae\| PubMed ID: 37407542	2023
Methylcrotonyl-CoA carboxylase subunit 1 (MCCA) regulates multidrug resistance in multiple myeloma. Life sciences\| PubMed ID: 37805164	2023
RNA-binding protein hnRNPU regulates multiple myeloma resistance to selinexor. Cancer letters\| PubMed ID: 37984724	2024
Influencing factors of cancer-related fatigue in acute leukemia patients: A cross-sectional study. Heliyon\| PubMed ID: 38144341	2023
Daratumumab-based immunotherapy vs. lenalidomide, bortezomib and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: a systemic review. Frontiers in oncology\| PubMed ID: 38333688	2024
Decreased RNA-binding protein heterogeneous nuclear ribonucleoprotein U improves multiple myeloma sensitivity to lenalidomide. British journal of haematology\| PubMed ID: 38685577	2024
Single-cell sequencing reveals the correlation of aggrephagy signaling and multiple myeloma immune microenvironment composition. The journal of gene medicine\| PubMed ID: 38949072	2024
Phase I study of TQB3602, an oral proteasome inhibitor, in relapsed and refractory multiple myeloma. Cancer medicine\| PubMed ID: 39031941	2024
Intravascular large B-cell lymphoma as a covert trigger for hemophagocytic lymphohistiocytosis complicated with capillary leak syndrome: a case report and literature review. Frontiers in immunology\| PubMed ID: 39072323	2024
Maintenance therapy for cytogenetically high-risk multiple myeloma: landscape in the era of novel drugs. Clinical and experimental medicine\| PubMed ID: 39105954	2024
Dihydrolipoamide dehydrogenase (DLD) is a novel molecular target of bortezomib. Cell death & disease\| PubMed ID: 39138149	2024
A predictive risk-scoring model for survival prognosis of multiple myeloma based on gain/amplification of 1q21: Experience in a tertiary hospital in South-Western China. Cancer medicine\| PubMed ID: 39234657	2024
Modest survival benefits of autologous stem cell transplantation in multiple myeloma with renal impairment: a critical appraisal of the pre-antibody era. Clinical and experimental medicine\| PubMed ID: 39249542	2024
Ferroptosis-related prognostic model of mantle cell lymphoma. Open medicine (Warsaw, Poland)\| PubMed ID: 39588389	2024
COMMD3 Regulates Copper Metabolism via the ATOX1-ATP7A-LOX Axis to Promote Multiple Myeloma Progression. Biomedicines\| PubMed ID: 40002764	2025